SCRN2 and neoplasm: Herein, we first report that secernin 2 (SCRN2), an uncharacterized gene in human cancer, acts as a novel tumor suppressor in TNBC to inhibit cancer progression and enhance therapeutic sensitivity to poly(ADP‐ribose) polymerase (PARP) inhibition both in vitro and in vivo.